Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Leceta

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Leukocyte Biology|January 15, 2003
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microgliaMario Delgado, Javier Leceta, Doina Ganea
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2002
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cellsMario Delgado, Javier Leceta, Doina Ganea
Frontiers in Immunology|August 2, 2021
Mechanism of Immunoregulatory Properties of Vasoactive Intestinal Peptide in the K/BxN Mice Model of Autoimmune ArthritisJavier Leceta, Marina I Garin, Carmen Conde
Peptides|March 25, 2008
VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4Alicia Arranz, Yasmina Juarranz, Javier Leceta, et al.
Neuroimmunomodulation|December 13, 2007
Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammationJavier Leceta, Rosa P Gomariz, Carmen Martinez, et al.
Fish & Shellfish Immunology|December 21, 2010
Differential expression pattern of pituitary adenylate cyclase-activating polypeptide (PACAP) alternative splicing variants and its receptors in the immune system of rainbow trout (Oncorhynchus mykiss)Juana Maria Lugo, Carolina Tafalla, Javier Leceta, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 26, 2012
VIP in inflammatory bowel disease: state of the artCatalina Abad, Rosa Gomariz, James Waschek, et al.
Neuroimmunomodulation|December 14, 2002
Pituitary adenylate-cyclase-activating polypeptide expression in the immune systemCatalina Abad, Carmen Martinez, Javier Leceta, et al.
Immunology and Cell Biology|March 24, 2010
New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetesRebeca Jimeno, Rosa P Gomariz, Irene Gutiérrez-Cañas, et al.
Annals of the New York Academy of Sciences|August 5, 2006
Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitisAlicia Arranz, Catalina Abad, Yasmina Juarranz, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Leukocyte Biology|January 15, 2003
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microgliaMario Delgado, Javier Leceta, Doina Ganea
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2002
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cellsMario Delgado, Javier Leceta, Doina Ganea
Frontiers in Immunology|August 2, 2021
Mechanism of Immunoregulatory Properties of Vasoactive Intestinal Peptide in the K/BxN Mice Model of Autoimmune ArthritisJavier Leceta, Marina I Garin, Carmen Conde
Peptides|March 25, 2008
VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4Alicia Arranz, Yasmina Juarranz, Javier Leceta, et al.
Neuroimmunomodulation|December 13, 2007
Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammationJavier Leceta, Rosa P Gomariz, Carmen Martinez, et al.
Fish & Shellfish Immunology|December 21, 2010
Differential expression pattern of pituitary adenylate cyclase-activating polypeptide (PACAP) alternative splicing variants and its receptors in the immune system of rainbow trout (Oncorhynchus mykiss)Juana Maria Lugo, Carolina Tafalla, Javier Leceta, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 26, 2012
VIP in inflammatory bowel disease: state of the artCatalina Abad, Rosa Gomariz, James Waschek, et al.
Neuroimmunomodulation|December 14, 2002
Pituitary adenylate-cyclase-activating polypeptide expression in the immune systemCatalina Abad, Carmen Martinez, Javier Leceta, et al.
Immunology and Cell Biology|March 24, 2010
New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetesRebeca Jimeno, Rosa P Gomariz, Irene Gutiérrez-Cañas, et al.
Annals of the New York Academy of Sciences|August 5, 2006
Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitisAlicia Arranz, Catalina Abad, Yasmina Juarranz, et al.
Pageof 3